Zona des sujets âgés [Herpes zoster in old adults].

Détails

ID Serval
serval:BIB_1CE716DEF151
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Zona des sujets âgés [Herpes zoster in old adults].
Périodique
Presse Médicale
Auteur⸱e⸱s
Lang P.O., Belmin J., Michel J.P.
ISSN
0755-4982 (Print)
ISSN-L
0755-4982
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
38
Numéro
4
Pages
571-583
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; Review Publication Status: ppublish
Résumé
The varicella-zoster virus is an exclusively human herpesvirus, responsible for chickenpox. Its reactivation, after several decades, causes herpes zoster (shingles). Herpes zoster produces a rash, classically metameric, that causes acute pain and complications to elderly patients. The last, most painful, and disabling of these is postherpetic neuralgia. This neuralgia is defined as a painful syndrome lasting for more than 30 days after eruption of the rash. Today's systemic antiviral drugs can reduce the severity of the eruption, limit the pain, and diminish the incidence of postherpetic neuralgia. A recent advance in primary prevention is approval of a vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia in subjects 60 years or older.
Mots-clé
Aged, Analgesics/therapeutic use, Antiviral Agents/therapeutic use, Cross-Sectional Studies, Herpes Zoster/diagnosis, Herpes Zoster/drug therapy, Herpes Zoster Vaccine/administration & dosage, Humans, Middle Aged, Neuralgia, Postherpetic/diagnosis, Neuralgia, Postherpetic/drug therapy, Risk Factors, Virus Activation
Pubmed
Web of science
Création de la notice
15/04/2015 9:41
Dernière modification de la notice
20/08/2019 12:53
Données d'usage